CD44 and neoplasm: Accumulating evidence suggests that chemotherapy targets the bulk of tumour cells, whereas CSC subpopulations of tumours show a reduced response to chemotherapeutic drugs.16 Compared with the ALDH−CD44− subset, ALDH+CD44+ SKOV3 cells exhibited greater chemoresistance (Fig. 2f).